EMEND

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug EMEND contains one active pharmaceutical ingredient (API):

1 Aprepitant UNII 1NF15YR6UY - APREPITANT

Aprepitant is a selective high-affinity antagonist at human substance P neurokinin 1 (NK1) receptors. Read about Aprepitant

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EMEND Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A04AD12	Aprepitant	A Alimentary tract and metabolism → A04 Antiemetics and antinauseants → A04A Antiemetics and antinauseants → A04AD Other antiemetics
Discover more medicines within A04AD12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 525503201119219
Country: CA	Health Products and Food Branch	Identifier(s): 02298791, 02298805, 02298813
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02364367, 02364404, 06117476, 06475738, 10220501, 10518235, 10541837, 11724965, 12346436, 12554413, 16861891
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 25.643-04-04, 25.655-04-04, 26.008-10-04
Country: EE	Ravimiamet	Identifier(s): 1203275, 1203286, 1203297, 1203309, 1203310, 1205345, 1315965, 1315976, 1552812, 1552823, 1708545
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 03262006
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 017331, 017436, 018520
Country: FR	Base de données publique des médicaments	Identifier(s): 60574505, 61951090, 66256064, 66824150
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 334566, 75296, 75303, 75309, 75310
Country: HK	Department of Health Drug Office	Identifier(s): 52423, 52424, 52425
Country: IE	Health Products Regulatory Authority	Identifier(s): 22443, 22472, 22508, 22517
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4969
Country: JP	医薬品医療機器総合機構	Identifier(s): 2391008M1021, 2391008M2028, 2391008M3024
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1027967, 1027968, 1027969, 1027970, 1027971, 1027972, 1027973, 1027974, 1064229, 1064230, 1079352
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 130M2003
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 132888, 75817, 75825, 85790
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11435
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100063463, 100068302, 100088322, 100309591, 100309622, 100369529
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64642001
Country: SG	Health Sciences Authority	Identifier(s): 12369P, 12371P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 3443141
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699636150306
Country: US	FDA, National Drug Code	Identifier(s): 0006-0461, 0006-0462, 0006-0464, 0006-3061, 0006-3066
Country: ZA	Health Products Regulatory Authority	Identifier(s): A38/5.7.2/0625, A38/5.7.2/0626, A38/5.7.2/0627